Filter announcements
Loading...
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.
Jubilant Pharmova Limited has informed the Exchange about General Updates
Jubilant Pharmova received a GST demand notice for Rs. 87.31 Cr (tax, interest, penalty) for FY2022-23. The company disputes the claim, calling it incorrect, and expects no financial or operational impact, planning a detailed reply.
Jubilant Pharmova Limited has informed the Exchange about Copy of Newspaper Publication - Re-lodgement and KYC Updation
Jubilant Generics (subsidiary) received a Show Cause Notice for alleged inadmissible IGST refund, demanding Rs. 52.75 Cr GST and Rs. 52.75 Cr penalty plus interest. The company contests this, stating it's incorrect and expects no financial impact.
Jubilant Pharmova Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 26, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.